Clinical Trial Update: VSV-IFNβ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating VSV-IFNβ-NIS in combination with ipilimumab and nivolumab for advanced or metastatic clear cell renal cell carcinoma; recruitment has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• OPDIVO (nivolumab)
• VSV-IFNβ-NIS (vesicular stomatitis virus expressing interferon-beta and NIS)
• Yervoy (ipilimumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING